Investing in cell-cultured meat is a calculated risk for investors, but “not a wild gamble,” says the co-founder and CEO of Dutch startup Meatable, who says he is confident that Meatable can put a “cost competitive product on the market by 2025.”
Dutch cell-cultured meat startup Meatable - which is working with porcine and bovine induced pluripotent stem cells [iPSCs] – has closed a $47m Series A round (bringing its total funding to $60m) to advance small-scale production at the Biotech Campus...
A new player in the burgeoning cell-based meat field that has developed a production process which its founders claim will give it a competitive advantage over rivals, has emerged from stealth mode after raising $3.5m to help scale its slaughter-free...